VERADIGM INC. news, videos and press releases
For more news please use our advanced search feature.
VERADIGM INC. - More news...
VERADIGM INC. - More news...
- Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices
- Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review
- Veradigm Announces the Resignation of Board Director Beth Altman Due to Health Reasons
- Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey
- Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
- Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden
- Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration
- Veradigm Payerpath Rated Highest in Client Satisfaction for Small Physician Practice Clearinghouse Services, 2024 Black Book Survey
- Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation
- Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation
- SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Veradigm Inc.- MDRX
- MDRX DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important January 22 Deadline in Securities Class Action - MDRX
- Deadline in 3 Days for Veradigm Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Veradigm Inc. (MDRX) Investors of Filing Deadline in Class Action Lawsuit
- SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 - (NASDAQ: MDRX)
- VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options
- SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Veradigm Investors of a Lead Plaintiff Deadline of January 22, 2024
- MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline
- ROSEN, A TOP RANKED LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with to Secure Counsel Before Important January 22 Deadline in Securities Class Action - MDRX
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX
- SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Veradigm Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 22, 2024 - (NASDAQ: MDRX)
- VERADIGM INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discuss Their Options
- MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit
- SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Veradigm Investors of a Lead Plaintiff Deadline of January 22, 2024
- MDRX Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Veradigm Inc. (MDRX)
- MDRX Investors Have Opportunity to Lead Veradigm Inc. Securities Fraud Lawsuit
- Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner
- SHAREHOLDER ALERT: Levi & Korsinsky Notifies Veradigm Inc.(MDRX) Investors of a Class Action Lawsuit and Upcoming Deadline
- ROSEN, A LONGSTANDING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MDRX
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Veradigm Inc. - MDRX
